Overview To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers Status: Completed Trial end date: 1987-05-01 Target enrollment: Participant gender: Summary To demonstrate the relative bioequivalency of generic Haloperidol tablets versus Haldol in normal volunteers. Phase: Phase 1 Details Lead Sponsor: SandozTreatments: HaloperidolHaloperidol decanoate